Pictet Asset Management (Switzerland)’s CureVac CVAC Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$136K	Buy	+13,011	New	+$116K	﹤0.01%	1806

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CVAC Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) opened a new position in CureVac (CVAC) in Q2 2023: 13,011 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings.

88 funds tracked by Wall St. Rank hold CVAC as of Q2 2023.

Pictet Asset Management (Switzerland) held 13,011 shares of CureVac worth $136K as of Q2 2023.
CureVac was a new Pictet Asset Management (Switzerland) position in Q2 2023.
CureVac made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1806 holding.
88 funds tracked by Wall St. Rank held CureVac as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.